[{"address1": "4902 Eisenhower Boulevard", "address2": "Suite 125", "city": "Tampa", "state": "FL", "zip": "33634", "country": "United States", "phone": "813 286 7900", "fax": "813 286 7904", "website": "https://www.oragenics.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Oragenics, Inc., a development-stage company, engages in the research and development of nasal delivery pharmaceutical medications in neurology and fighting infectious diseases in the United States. Its lead product is ONP-002, a fully synthetic, non-naturally occurring neurosteroid which is lipophilic and can cross the blood-brain barrier to reduce swelling, oxidative stress, and inflammation while restoring proper blood flow through gene amplification. The company also develops NT-CoV2-1, a SARS-CoV-2 vaccine product candidate; and Lantibiotic Product Candidate, such as Mutacin 1140 (MU1140), a molecule belonging to the novel class of antibiotics. It has a license agreement with Inspirevax Inc. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.", "companyOfficers": [{"maxAge": 1, "name": "Mr. Greg  Gironda", "title": "Chief Operating Officer", "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. William Franklin Peacock IV, F.A.C.E.P., FACC, M.D.", "title": "Chief Clinical Officer", "exercisedValue": 0, "unexercisedValue": 0}], "irWebsite": "http://www.oragenics.com/?q=investors", "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 0.26, "open": 0.26, "dayLow": 0.2461, "dayHigh": 0.2624, "regularMarketPreviousClose": 0.26, "regularMarketOpen": 0.26, "regularMarketDayLow": 0.2461, "regularMarketDayHigh": 0.2624, "payoutRatio": 0.0, "beta": 0.848, "forwardPE": -0.023666667, "volume": 259229, "regularMarketVolume": 259229, "averageVolume": 5289541, "averageVolume10days": 377960, "averageDailyVolume10Day": 377960, "bid": 0.2513, "ask": 0.2597, "bidSize": 10, "askSize": 8, "marketCap": 3504225, "fiftyTwoWeekLow": 0.24, "fiftyTwoWeekHigh": 3.43, "fiftyDayAverage": 0.2948, "twoHundredDayAverage": 0.65285, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 5047263, "profitMargins": 0.0, "floatShares": 16526953, "sharesOutstanding": 13709800, "sharesShort": 392595, "sharesShortPriorMonth": 2134158, "sharesShortPreviousMonthDate": 1738281600, "dateShortInterest": 1740700800, "sharesPercentSharesOut": 0.0286, "heldPercentInsiders": 0.133, "heldPercentInstitutions": 0.011360001, "shortRatio": 0.03, "shortPercentOfFloat": 0.0346, "impliedSharesOutstanding": 14131600, "bookValue": -0.017, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -10567918, "trailingEps": -6.97, "forwardEps": -10.8, "lastSplitFactor": "1:60", "lastSplitDate": 1674432000, "enterpriseToEbitda": -0.479, "52WeekChange": -0.81294966, "SandP52WeekChange": 0.07465422, "quoteType": "EQUITY", "currentPrice": 0.2556, "targetHighPrice": 1.0, "targetLowPrice": 1.0, "targetMeanPrice": 1.0, "targetMedianPrice": 1.0, "recommendationMean": 3.0, "recommendationKey": "hold", "numberOfAnalystOpinions": 1, "totalCash": 864840, "totalCashPerShare": 0.04, "ebitda": -10531424, "totalDebt": 328528, "quickRatio": 0.513, "currentRatio": 0.874, "returnOnAssets": -2.04983, "returnOnEquity": -7.1495, "grossProfits": -4114434, "freeCashflow": -6447050, "operatingCashflow": -8597382, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "OGEN", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "longName": "Oragenics, Inc.", "shortName": "Oragenics Inc.", "marketState": "REGULAR", "corporateActions": [], "priceToBook": -15.035294, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "averageAnalystRating": "3.0 - Hold", "cryptoTradeable": false, "regularMarketTime": 1742412087, "exchange": "ASE", "messageBoardId": "finmb_774436", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "regularMarketChangePercent": -1.666661, "regularMarketPrice": 0.2556, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1077719400000, "regularMarketChange": -0.004399985, "regularMarketDayRange": "0.2461 - 0.2624", "fullExchangeName": "NYSE American", "averageDailyVolume3Month": 5289541, "fiftyTwoWeekLowChange": 0.015600011, "fiftyTwoWeekLowChangePercent": 0.06500005, "fiftyTwoWeekRange": "0.24 - 3.43", "fiftyTwoWeekHighChange": -3.1744, "fiftyTwoWeekHighChangePercent": -0.9254811, "fiftyTwoWeekChangePercent": -81.29497, "dividendDate": 1516579200, "earningsTimestamp": 1741982400, "earningsTimestampStart": 1747155600, "earningsTimestampEnd": 1747674000, "isEarningsDateEstimate": true, "epsTrailingTwelveMonths": -6.97, "epsForward": -10.8, "fiftyDayAverageChange": -0.039200008, "fiftyDayAverageChangePercent": -0.13297153, "twoHundredDayAverageChange": -0.39724997, "twoHundredDayAverageChangePercent": -0.6084858, "displayName": "Oragenics", "trailingPegRatio": null, "__fetch_time": "2025-03-19"}]